共 50 条
- [3] Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma Cancer Chemotherapy and Pharmacology, 2016, 78 : 1237 - 1244
- [10] Population pharmacokinetic and exposure–response analyses of elotuzumab plus pomalidomide and dexamethasone for relapsed and refractory multiple myeloma Cancer Chemotherapy and Pharmacology, 2022, 89 : 129 - 140